Can You ID ADHD? Tips and Tools to Improve Your Rate of Detection in Adults


Ann Childress, MD
President, Center for Psychiatry and Behavioral Medicine, Inc.
Associate Professor Child/Adolescent Psychiatry
Touro University Nevada College of Osteopathic Medicine, Henderson, NV
Clinical Associate Professor, University of Nevada, Las Vegas School of Medicine, Las Vegas, NV
Ann Childress, MD

Before earning her medical degree at the Medical University of South Carolina, Charleston, Dr. Childress studied at St. Louis University School of Medicine, St. Louis, Missouri. She completed a psychiatry internship and residency as well as a fellowship in child and adolescent psychiatry at the Medical University of South Carolina in Charleston, South Carolina.

Today, roughly 80% of her practice is research-based. She also has adjunct faculty appointments at the University of Nevada Las Vegas School of Medicine and Touro University Nevada College of Osteopathic Medicine. Dr. Childress is board certified in psychiatry, with a subspecialty in child and adolescent psychiatry.Dr. Childress has authored numerous publications on the topic of ADHD. As Co-Principal Investigator, she has participated in more than 175 clinical trials.

Dr. Childress is also a distinguished fellow of the American Psychiatric Association and a member of the American Academy of Child and Adolescent Psychiatry. She is President of The American Professional Society of ADHD and Related Disorders, and is Education Director for the Nevada Psychiatric Association.

Theresa Cerulli, MD
Neuropsychiatrist, Beth Israel Deaconess Medical Center, Boston, MA, Medical Director, Cerulli and Associates, North Andover, MA
Theresa Cerulli, MD

Theresa Cerulli, MD, is a graduate of Tufts University, University of Massachusetts Medical School, Harvard Longwood Residency Program in Adult Psychiatry, and Harvard Fellowships in Medical Psychiatry and Neuropsychiatry. Dr. Cerulli is Board Certified in Psychiatry and is on faculty at Beth Israel Deaconess Medical Center in Boston and recently presented as faculty at NEI, Neuroscience Education Institute.

She received the 1997 Harvard Residency Teaching Award and has published several journal articles in the Harvard Review of Psychiatry and Journal of Medicine. Dr. Cerulli has continued in her role as a member of the Harvard Medical School faculty as a Clinical Instructor at Beth Israel Deaconess Medical Center in Boston, lecturing on a range of neuropsychiatric topics including attention deficit disorder, depression, bipolar disorder, and schizophrenia. She is a supervisor for the Harvard Longwood Residency Training Program.

Dr. Cerulli is the co-founder and prior Chief Medical Officer of ADD Health and Wellness Centers, specializing in the holistic treatment of children and adults with ADD/ADHD and co-existing behavioral health conditions. Her vision is in combining traditional medicine with healthy living to promote cognitive and emotional well-being. She previously served as Medical Director for the Hallowell Center and co-founder of Hallowell ADDvance. Dr. Cerulli has served as a national expert witness in over 20 child and adult psychiatric legal cases. Since 2003 she has presented nationally and internationally as a consultant and speaker in the pharmaceutical industry with various companies including Shire Pharmaceuticals, Eli Lilly, Novartis, Allergan, Takeda, Sunovion, Supernus, Abbvie, Neos, and Cingulate Therapeutics in their CNS divisions. She was a sub-investigator with East Coast Clinical Research for two phase IV psychotropic medication trials and is certified by the Major League Baseball Commission (MLB) to conduct player therapeutic use exemption (TUE) evaluations for major and minor league players.

Familiar with the media, Dr. Cerulli has appeared on numerous television programs: channel 7 Urban Update for a debate on the use of psychotropic medications in children, channel 5 ABC Evening News for a segment on learning disabilities, and WMUR Evening News to discuss integrating mental health care. Dr. Cerulli was also interviewed on TV channel 56’s Health Watch regarding the use of Quantitative EEG and moderated a series of psychiatric expert panel discussions on Her other media appearances include interviews with local radio stations WBCN, WESO, Radio Disney, and the Frankie Boyer Show as well as several newspaper and magazine articles. She volunteered as a medical advisory board member of Kiwi magazine. Most recently Dr. Cerulli was filmed in the Dr. Mom ADHD video series and as the moderator and ADHD expert panelist on, as well as a national satellite news media tour on the topic “Back to School with ADHD,” August 2021.

Statement of Need

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that varies in its symptom presentation and functional impact across the lifespan. Although it is now recognized that ADHD may persist to adulthood, it often goes undetected in adults, being misdiagnosed as other psychiatric and frequently comorbid conditions. Diagnosis is complicated in that symptom presentation may vary as the individual transitions from childhood to adulthood. The use of diagnostic criteria and evidence-based tools can help to differentiate the diagnosis of ADHD in adults, particularly in the context of comorbidities. This is imperative because an accurate diagnosis not only facilitates early intervention but also offers a sense of relief as difficulties experienced at home and work are now explained.

This CME Outfitters activity will provide clinicians with the appropriate tools to facilitate the early detection of ADHD in adults, particularly within the context of comorbidities.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Utilize updated diagnostic criteria and screening tools to accurately diagnose ADHD in adults.

Financial Support

Supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc.

Target Audience

Psychiatrists, psychiatric nurses, pediatricians, primary care providers, PAs, nurse practitioners, nurses, and pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.0

This activity is designated for 1.0 contact hour.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit  from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.

PAs (AAPA) 1.0

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Childress reports that she receives research support from Adlon Therapeutics L.P.; Akili Interactive Labs, Inc.; Allergan; Arbor Pharmaceuticals; KemPharm, Inc.; Neos Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Purdue Pharma L.P.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Tris Pharma, Inc. She reports that she is on the speakers bureau for Corium Inc.; Ironshore Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and Tris Pharma, Inc. She reports that she is a consultant for Aardvark Therapeutics, Inc.; Corium Inc.; Jazz Pharmaceuticals, Inc.; KemPharm, Inc.; Lumos Pharma; Neos Therapeutics, Inc.; Noven Pharmaceuticals, Inc.; Sunovion Pharmaceuticals Inc.; Supernus Pharmaceuticals, Inc.; and Tulex Pharmaceuticals. She reports that she receives writing support for Purdue Pharma L.P.; Supernus Pharmaceuticals, Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Dr. Cerulli has no disclosures to report.

  • S. Michelle Franks, MSN, APRN, FNP-BC (peer reviewer) has no disclosures to report.
  • Kashemi D. Rorie, PhD (planning committee) has no disclosures to report.
  • Susan Perry (planning committee) has no disclosures to report.
  • Susan H. Yarbrough, CHCP (planning committee) has no disclosures to report.
  • Jan Perez (planning committee) has no disclosures to report.
  • Sharon Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit

Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767.


Can You ID ADHD? Tips and Tools to Improve Your Rate of Detection in Adults
Event Date: 12/30/2021